Editorial: Small molecules and biologics for future purinergic therapeutics

被引：1

作者：

Jacobson, Kenneth A. ^{[1
]}

Salvemini, Daniela ^{[2
,3
]}

机构：

[1] Natl Inst Diabet & Digest & Kidney Dis, NIH, Mol Recognit Sect, Lab Bioorgan Chem, Bethesda, MD 20892 USA

[2] St Louis Univ, Dept Pharmacol & Physiol, Sch Med, 1402 South Grand Blvd, St Louis, MO 63104 USA

[3] St Louis Univ, Henry & Amelia Nasrallah Ctr Neurosci, Sch Med, 1402 South Grand Blvd, St Louis, MO 63104 USA

来源：

PURINERGIC SIGNALLING | 2023年 / 19卷 / 03期

关键词：

Drug discovery; Adenosine; G protein-coupled purinergic receptors; ATP; Purinergic signalling; Ligand-gated P2X receptors channels;

D O I：

10.1007/s11302-023-09964-9

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Receptor agonists and antagonists and other modulators of purinergic signalling have potential as novel therapeutics for a broad range of diseases and conditions. This special issue focuses on compounds or approaches that are either in clinical trials or headed in that direction. It is intended to serve as an up-to-date description of selected efforts to discover and develop new small molecular purinergic drugs.

引用

页码：465 / 466

页数：2

共 7 条

[1]

[Anonymous], 2023, KLAVER

[2] International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update [J].

IJzerman, Adriaan P. ;

Jacobson, Kenneth A. ;

Mueller, Christa E. ;

Cronstein, Bruce N. ;

Cunha, Rodrigo A. .

PHARMACOLOGICAL REVIEWS, 2022, 74 (02) :340-372

[3] Update of P2X receptor properties and their pharmacology: IUPHAR Review 30 [J].

Illes, Peter ;

Mueller, Christa E. ;

Jacobson, Kenneth A. ;

Grutter, Thomas ;

Nicke, Annette ;

Fountain, Samuel J. ;

Kennedy, Charles ;

Schmalzing, Gunther ;

Jarvis, Michael F. ;

Stojilkovic, Stanko S. ;

King, Brian F. ;

Di Virgilio, Francesco .

BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (03) :489-514

[4]

Jacobson KA, 2020, BRIT J PHARMACOL, V177, P2413, DOI [10.1111/bph.15005, 10.1111/bph.1500510.1111/bph.15005]

[5] Blockade of P2X4 Receptors Inhibits Neuropathic Pain-Related Behavior by Preventing MMP-9 Activation and, Consequently, Pronociceptive Interleukin Release in a Rat Model [J].

Jurga, Agnieszka M. ;

Piotrowska, Anna ;

Makuch, Wioletta ;

Przewlocka, Barbara ;

Mika, Joanna .

FRONTIERS IN PHARMACOLOGY, 2017, 8

[6] A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain [J].

Matsumura, Yuta ;

Yamashita, Tomohiro ;

Sasaki, Atsushi ;

Nakata, Eriko ;

Kohno, Keita ;

Masuda, Takahiro ;

Tozaki-Saitoh, Hidetoshi ;

Imai, Toshiyasu ;

Kuraishi, Yasushi ;

Tsuda, Makoto ;

Inoue, Kazuhide .

SCIENTIFIC REPORTS, 2016, 6

[7] Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation [J].

Richards, David ;

Gever, Joel R. ;

Ford, Anthony P. ;

Fountain, Samuel J. .

BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (13) :2279-2291

← 1 →